Stephen Y. Nakada

Medical expulsive therapy or bust?
Medical expulsive therapy or bust?Whether or not medical expulsive therapy (MET) is a sound recommendation for patients with kidney or ureteral stones is a matter of debate.
MUSIC: How statewide initiative is improving care, outcomesIn this interview, Khurshid R. Ghani, MD, and David C. Miller, MD, MPH, discuss the origins of the Michigan Urological Surgery Improvement Collaborative, what it’s done for prostate cancer care in Michigan, and how a similar model could be rolled out nationally.
Urology work force faces gender pay gap, shortage
Urology work force faces gender pay gap, shortageIn this interview, Angela B. Smith, MD, MS, discusses two work force problems in urology, discrepancies in male and female urologist compensation, and solutions for these issues.
AUA 2016: Experts offer guidance on the meetingTo guide you through the 2016 AUA annual meeting and help maximize your time, Urology Times’ editorial board has reviewed the program to identify the key trends and noteworthy research at this year’s meeting.
Urolithiasis: Genetics and lifestyle rule"With better education and research, our stone patients can decrease their disease risk and improve their overall health sooner rather than later," writes Stephen Y. Nakada, MD.
Difficult stones present treatment, training challenges
Difficult stones present treatment, training challengesIn this interview, Dr. Wong describes difficult stones, discusses the skills and training required to treat them, and outlines the role of different treatment modalities.
Breaking new ground (and kidney stones) with ultrasoundNovel ultrasound-based techniques for propelling and breaking kidney stones could soon join ESWL and URS in the urologist’s treatment armamentarium. In this interview, Michael Bailey, PhD, discusses how these technologies work, what they’re capable of, and where they are in development.
Top read in February: AUA statement on NPs/PAsCatch up on February’s best-read Urology Times articles, including our coverage of the AUA’s recent statement on NPs/PAs, a malpractice case involving removal of a cancer-free testicle, and a Q&A on diversity in urology.
'We embrace diversity,' but must do more to competeMore work needs to be done to expand the role of minorities and women in urology leadership positions and to stay competitive with other specialties, Tracy M. Downs, MD, explains in this interview.
Two-drug therapy fails to improve stent discomfortAdding an anticholinergic medication to an alpha-blocker does not appear to improve ureteral stent-related discomfort compared to monotherapy with an alpha-blocker alone, according to research presented by investigators from the University of Wisconsin, Madison.